IBT — IBEX Technologies Share Price
0.000.00%
Last trade - 00:00- CA$35.29m
- CA$28.17m
- CA$7.49m
- 80
- 59
- 70
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.48 | ||
| Price to Tang. Book | 2.48 | ||
| Price to Free Cashflow | 19.86 | ||
| Price to Sales | 4.41 | ||
| EV to EBITDA | 13.67 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.03% | ||
| Return on Equity | 32.26% | ||
| Operating Margin | 19.48% | ||
Financial Summary
| Year End 31st Jul | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 4.31 | 5.21 | 5.31 | 7.89 | 7.49 | n/a | n/a | 9.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -23.41 | +119.85 | +132.96 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.
Directors
- Paul Baehr CHM (76)
- Belinda Franco FID
- Mahendra Pallapothu VOP
- Robert Deluccia LED (73)
- Christine Charette DRC
- Bruce Connop IND (47)
- Danilo Netto IND
- Joseph Zimmermann IND
- Last Annual
- July 31st, 2023
- Last Interim
- January 31st, 2024
- Incorporated
- September 2nd, 1977
- Public Since
- November 14th, 1985
- No. of Employees
- 15
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 24,507,644
- Address
- Suite 100, 5485 Pare Street, MONTREAL, H4P 1P7
- Web
- https://www.ibex.ca/
- Phone
- +1 5143444004
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for IBT
Similar to IBT
Arch Biopartners
TSX Venture Exchange
biOasis Technologies
TSX Venture Exchange
Ceapro
TSX Venture Exchange
Covalon Technologies
TSX Venture Exchange
Hemostemix
TSX Venture Exchange
FAQ
What is the IBEX Technologies share price?
As of Today at 19:11 UTC, shares in IBEX Technologies are trading at CA$1.44. This share price information is delayed by 15 minutes.
How has the IBEX Technologies share price performed this year?
Shares in IBEX Technologies last closed at CA$1.44 and the price had moved by +89.47% over the past 365 days. In terms of relative price strength the IBEX Technologies share price has outperformed the Toronto Stock Exchange 300 Composite Index by +72.55% over the past year.
What are the analyst and broker recommendations for IBEX Technologies?
There is no consensus recommendation for this security.
What is the IBEX Technologies dividend yield?
IBEX Technologies does not currently pay a dividend.
Does IBEX Technologies pay a dividend?
IBEX Technologies does not currently pay a dividend.
When does IBEX Technologies next pay dividends?
IBEX Technologies does not currently pay a dividend.
How do I buy IBEX Technologies shares?
To buy shares in IBEX Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of IBEX Technologies?
As of the previous close price of CA$1.44, shares in IBEX Technologies had a market capitalisation of CA$35.29m.
Where are IBEX Technologies shares listed?
Here are the trading details for IBEX Technologies:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: IBT
What kind of share is IBEX Technologies?
Based on an overall assessment of its quality, value and momentum IBEX Technologies is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a IBEX Technologies share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the IBEX Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like IBEX Technologies. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +30.03%.
As of the last closing price of CA$1.44, shares in IBEX Technologies were trading +30.52% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the IBEX Technologies PE Ratio?
The IBEX Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$1.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of IBEX Technologies?
IBEX Technologies' management team is headed by:
- Paul Baehr - CHM
- Belinda Franco - FID
- Mahendra Pallapothu - VOP
- Robert Deluccia - LED
- Christine Charette - DRC
- Bruce Connop - IND
- Danilo Netto - IND
- Joseph Zimmermann - IND